Regulation of myocardial contractility and cell size by distinct PI3K-PTEN signaling pathways

Cell

Volumn 110, Issue 6, 2002, Pages 737-749

  Crackower, Michael A ^a,b   Oudit, Gavin Y ^c   Kozieradzki, Ivona ^a,b   Sarao, Renu ^a,b   Sun, Hui ^c   Sasaki, Takehiko ^d,e   Hirsch, Emilio ^f   Suzuki, Akira ^g   Shioi, Tetsuo ^h   Irie Sasaki, Junko ^d,e   Sah, Rajan ^c   Cheng, Hai Ying M ^a,b   Rybin, Vitalyi O ⁱ   Lembo, Giuseppe ^j   Fratta, Luigi ^j   Oliveira dos Santos, Antonio J ^b   Benovic, Jeffery L ^k   Kahn, C Ronald ^h   Izumo, Seigo ^h   Steinberg, Susan F ⁱ   Wymann, Matthias P ^l   Backx, Peter H ^c   Penninger, Josef M ^a,b   more..

^a INSTITUTE OF MOLECULAR BIOTECHNOLOGY   (Austria)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY HEALTH NETWORK   (Canada)

^d TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

^e JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^f UNIVERSITY OF TURIN   (Italy)

^g AKITA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^h HARVARD MEDICAL SCHOOL   (United States)

ⁱ Och Spine at New York Presbyterian Hospitals   (United States)

^j IRCCS NEUROMED   (Italy)

^k THOMAS JEFFERSON UNIVERSITY   (United States)

^l UNIVERSITY OF FRIBOURG   (Switzerland)

more..

Author keywords

[No Author keywords available]

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; ACTIN; ADENOSINE TRIPHOSPHATASE (CALCIUM); BETA ADRENERGIC RECEPTOR; CYCLIC AMP; FORSKOLIN; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PHOSPHOLAMBAN;

ALLELE; ANIMAL TISSUE; ARTICLE; CELL SIZE; CONTROLLED STUDY; ECHOCARDIOGRAPHY; GENE EXPRESSION; HEART FUNCTION; HEART HYPERTROPHY; HEART MUSCLE CELL; HEART MUSCLE CONTRACTILITY; HEMODYNAMICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RECEPTOR DENSITY; SKELETAL MUSCLE;

ANIMALIA;

EID: 18644372367     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0092-8674(02)00969-8     Document Type: Article

References (47)

1. Alessi D.R., Kozlowski M.T., Weng Q.P., Morrice N., Avruch J. 3-Phosphoinositide-dependent protein kinase 1 (PDK1) phosphorylates and activates the p70 S6 kinase in vivo and in vitro. Curr. Biol. 8:1998;69-81.
2. Backman S.A., Stambolic V., Suzuki A., Haight J., Elia A., Pretorius J., Tsao M.S., Shannon P., Bolon B., Ivy G.O., Mak T.W. Deletion of Pten in mouse brain causes seizures, ataxia and defects in soma size resembling Lhermitte-Duclos disease. Nat. Genet. 29:2001;396-403.
3. Baliga R.R., Pimental D.R., Zhao Y.Y., Simmons W.W., Marchionni M.A., Sawyer D.B., Kelly R.A. NRG-1-induced cardiomyocyte hypertrophy. Role of PI-3-kinase, p70(S6K), and MEK-MAPK-RSK. Am. J. Physiol. 277:1999;H2026-H2037.
4. Bondeva T., Pirola L., Bulgarelli-Leva G., Rubio I., Wetzker R., Wymann M.P. Bifurcation of lipid and protein kinase signals of PI3Kγ to the protein kinases PKB and MAPK. Science. 282:1998;293-296.
5. Brittsan A.G., Kranias E.G. Phospholamban and cardiac contractile function. J. Mol. Cell. Cardiol. 32:2000;2131-2139.
6. Bruning J.C., Michael M.D., Winnay J.N., Hayashi T., Horsch D., Accili D., Goodyear L.J., Kahn C.R. A muscle-specific insulin receptor knockout exhibits features of the metabolic syndrome of NIDDM without altering glucose tolerance. Mol. Cell. 2:1998;559-569.
7. Colan S.D. Mechanics of left ventricular systolic and diastolic function in physiologic hypertrophy of the athlete's heart. Cardiol. Clin. 15:1997;355-372.
8. Crackower M.A., Sarao R., Oudit G.Y., Yagil C., Kozieradzki I., Scanga S.E., Oliveira-dos-Santos A.J., da Costa J., Zhang L., Pei Y.et al. Angiotensin-converting enzyme 2 is an essential regulator of heart function. Nature. 417:2002;822-828.
9. Di Cristofano A., Pesce B., Cordon-Cardo C., Pandolfi P.P. Pten is essential for embryonic development and tumour suppression. Nat. Genet. 19:1998;348-355.
10. Downward J. Mechanisms and consequences of activation of protein kinase B/Akt. Curr. Opin. Cell Biol. 10:1998;262-267.
11. Frank K., Kranias E.G. Phospholamban and cardiac contractility. Ann. Med. 32:2000;572-578.
12. Franke T.F., Kaplan D.R., Cantley L.C., Toker A. Direct regulation of the Akt proto-oncogene product by phosphatidylinositol-3,4-bisphosphate. Science. 275:1997;665-668.
13. Hirsch E., Katanaev V.L., Garlanda C., Azzolino O., Pirola L., Silengo L., Sozzani S., Mantovani A., Altruda F., Wymann M.P. Central role for G protein-coupled phosphoinositide 3-kinase γ in inflammation. Science. 287:2000;1049-1053.
14. Hunter J.J., Chien K.R. Signaling pathways for cardiac hypertrophy and failure. N. Engl. J. Med. 341:1999;1276-1283.
15. Kodama H., Fukuda K., Pan J., Sano M., Takahashi T., Kato T., Makino S., Manabe T., Murata M., Ogawa S. Significance of ERK cascade compared with JAK/STAT and PI3-K pathway in gp130-mediated cardiac hypertrophy. Am. J. Physiol. Heart Circ. Physiol. 279:2000;H1635-H1644.
16. Komalavilas P., Mehta S., Wingard C.J., Dransfield D.T., Bhalla J., Woodrum J.E., Molinaro J.R., Brophy C.M. PI3-kinase/Akt modulates vascular smooth muscle tone via cAMP signaling pathways. J. Appl. Physiol. 91:2001;1819-1827.
17. Kuznetsov V., Pak E., Robinson R.B., Steinberg S.F. β2-adrenergic receptor actions in neonatal and adult rat ventricular myocytes. Circ. Res. 76:1995;40-52.
18. Leevers S.J., Weinkove D., MacDougall L.K., Hafen E., Waterfield M.D. The Drosophila phosphoinositide 3-kinase Dp110 promotes cell growth. EMBO J. 15:1996;6584-6594.
19. Li Z., Jiang H., Xie W., Zhang Z., Smrcka A.V., Wu D. Roles of PLC-β2 and -β3 and PI3Kγ in chemoattractant-mediated signal transduction. Science. 287:2000;1046-1049.
20. Lefkowitz R.J. G protein-coupled receptors III. New roles for receptor kinanses and β-arrestins in receptor signalling and desensitization. J. Biol. Chem. 273:1998;18677-18680.
21. Maehama T., Dixon J.E. The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-triphosphate. J. Biol. Chem. 273:1998;13375-13378.
22. Matsui T., Li L., Wu J.C., Cook S.A., Nagoshi T., Picard M.H., Liao R., Rosenzweig A. Phenotypic spectrum caused by transgenic overexpression of activated Akt in the heart. J. Biol. Chem. 277:2002;22896-22901. 10.1074/jbc.M200347200Published online April 9, 2002.
23. Milligan G., White J.H. Protein-protein interactions at G-protein-coupled receptors. Trends Pharmacol. Sci. 22:2001;513-518.
24. Minamisawa S., Hoshijima M., Chu G., Ward C.A., Frank K., Gu Y., Martone M.E., Wang Y., Ross J. Jr., Kranias E.G.et al. Chronic phospholamban-sarcoplasmic reticulum calcium ATPase interaction is the critical calcium cycling defect in dilated cardiomyopathy. Cell. 99:1999;313-322.
25. Naga Prasad S.V., Esposito G., Mao L., Koch W.J., Rockman H.A. Gβγ-dependent phosphoinositide 3-kinase activation in hearts with in vivo pressure overload hypertrophy. J. Biol. Chem. 275:2000;4693-4698.
26. Naga Prasad S.V., Barak L.S., Rapacciuolo A., Caron M.G., Rockman H.A. Agonist-dependent recruitment of phosphoinositide 3-kinase to the membrane by β-adrenergic receptor kinase 1. A role in receptor sequestration. J. Biol. Chem. 276:2001;18953-18959. a.
27. Naga Prasad S.V., Nienaber J., Rockman H.A. β-adrenergic axis and heart disease. Trends Genet. 17:2001;S44-S49. b.
28. Rabkin S.W., Goutsouliak V., Kong J.Y. Angiotensin II induces activation of phosphatidylinositol 3-kinase in cardiomyocytes. J. Hypertens. 15:1997;891-899.
29. Rockman H.A., Koch W.J., Lefkowitz R.J. Seven-transmembrane-spanning receptors and heart function. Nature. 415:2002;206-212.
30. Sah R., Oudit G.Y., Nguyen T.T., Lim H.W., Wickenden A.D., Wilson G.J., Molkentin J.D., Backx P.H. Inhibition of calcineurin and sarcolemmal Ca2+ influx protects cardiac morphology and ventricular function in K(v)4.2N transgenic mice. Circulation. 105:2002;1850-1856.
31. Sasaki T., Irie-Sasaki J., Jones R.G., Oliveira-dos-Santos A.J., Stanford W.L., Bolon B., Wakeham A., Itie A., Bouchard D., Kozieradzki I.et al. Function of PI3Kγ in thymocyte development, T cell activation, and neutrophil migration. Science. 287:2000;1040-1046.
32. Scanga S.E., Ruel L., Binari R.C., Snow B., Stambolic V., Bouchard D., Peters M., Calvieri B., Mak T.W., Woodgett J.R., Manoukian A.S. The conserved PI3′K/PTEN/Akt signaling pathway regulates both cell size and survival in Drosophila. Oncogene. 19:2000;3971-3977.
33. Schluter K.D., Simm A., Schafer M., Taimor G., Piper H.M. Early response kinase and PI 3-kinase activation in adult cardiomyocytes and their role in hypertrophy. Am. J. Physiol. 276:1999;H1655-H1663.
34. Schwartzbauer G., Robbins J. The tumor suppressor gene PTEN can regulate cardiac hypertrophy and survival. J. Biol. Chem. 276:2001;35786-35793.
35. Shima H., Pende M., Chen Y., Fumagalli S., Thomas G., Kozma S.C. Disruption of the p70(s6k)/p85(s6k) gene reveals a small mouse phenotype and a new functional S6 kinase. EMBO J. 17:1998;6649-6659.
36. Shioi T., Kang P.M., Douglas P.S., Hampe J., Yballe C.M., Lawitts J., Cantley L.C., Izumo S. The conserved phosphoinositide 3-kinase pathway determines heart size in mice. EMBO J. 19:2000;2537-2548.
37. Shioi T., McMullen J.R., Kang P.M., Douglas P.S., Obata T., Franke T.F., Cantley L.C., Izumo S. Akt/protein kinase B promotes organ growth in transgenic mice. Mol. Cell. Biol. 22:2002;2799-2809.
38. Steinberg S.F., Robinson R.B., Lieberman H.B., Stern D.M., Rosen M.R. Thrombin modulates phosphoinositide metabolism, cytosolic calcium, and impulse initiation in the heart. Circ. Res. 68:1991;1216-1229.
39. Steinberg S.F., Zhang H., Pak E., Pagnotta G., Boyden P.A. Characteristics of the β-adrenergic receptor complex in the epicardial border zone of the 5-day infarcted canine heart. Circulation. 9:1995;2824-2833.
40. Stephens L., Eguinoa A., Corey S., Jackson T., Hawkins P.T. Receptor stimulated accumulation of phosphatidylinositol (3,4,5)-trisphosphate by G-protein mediated pathways in human myeloid derived cells. EMBO J. 12:1993;2265-2273.
41. Suzuki A., de la Pompa J.L., Stambolic V., Elia A.J., Sasaki T., del Barco Barrantes I., Ho A., Wakeham A., Itie A., Khoo W.et al. High cancer susceptibility and embryonic lethality associated with mutation of the PTEN tumor suppressor gene in mice. Curr. Biol. 8:1998;1169-1178.
42. Suzuki A., Yamaguchi M.T., Ohteki T., Sasaki T., Kaisho T., Kimura Y., Yoshida R., Wakeham A., Higuchi T., Fukumoto M.et al. T cell-specific loss of Pten leads to defects in central and peripheral tolerance. Immunity. 14:2001;523-534.
43. Tamura M., Gu J., Matsumoto K., Aota S., Parsons R., Yamada K.M. Inhibition of cell migration, spreading, and focal adhesions by tumor suppressor PTEN. Science. 280:1998;1614-1617.
44. Toker A., Cantley L.C. Signalling through the lipid products of phosphoinositide-3-OH kinase. Nature. 387:1997;673-676.
45. Yusuf S., Reddy S., Ounpuu S., Anand S. Global burden of cardiovascular diseases Part I. General considerations, the epidemiologic transition, risk factors, and impact of urbanization Circulation. 104:2001;2746-2753.
46. Xiao R.P., Avdonin P., Zhou Y.Y., Cheng H., Akhter S.A., Eschenhagen T., Lefkowitz R.J., Koch W.J., Lakatta E.G. Coupling of β2-adrenoceptor to Gi proteins and its physiological relevance in murine cardiac myocytes. Circ. Res. 84:1999;43-52.
47. Zvaritch E., Backx P.H., Jirik F., Kimura Y., de Leon S., Schmidt A.G., Hoit B.D., Lester J.W., Kranias E.G., MacLennan D.H. The transgenic expression of highly inhibitory monomeric forms of phospholamban in mouse heart impairs cardiac contractility. J. Biol. Chem. 275:2000;14985-14991.